SCHEMBL6795186

SCHEMBL6795186

O=C(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)nc1nnnn12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FNTA P49354 5/20 0.54
FNTB P49356 5/20 0.54
PGGT1B P53609 2/20 0.54
CHEK1 O14757 1/20 0.40
LIMK1 P53667 1/20 0.40
MAPK14 Q16539 1/20 0.40
CLK4 Q9HAZ1 1/20 0.40
RORB Q92753 1/20 0.38
CSNK2A2 P19784 1/20 0.37
CSNK2B P67870 1/20 0.37
TP53 P04637 2/20 0.37
HSD11B1 P28845 1/20 0.36
MAPT P10636 2/20 0.35
RORC P51449 1/20 0.34
GRM5 P41594 1/20 0.34
USP2 O75604 1/20 0.34
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6801379 0.93 FNTA (0.48) FNTAFNTBPGGT1BCHEK1LIMK1
SCHEMBL14588485 0.82 FNTA (0.51) FNTAFNTBPGGT1BCHEK1LIMK1
SCHEMBL5657267 0.80 FNTA (0.54) FNTAFNTBPGGT1BHSD11B1TSHR
SCHEMBL11441866 0.78 FNTA (0.52) FNTAFNTBPGGT1BCHEK1LIMK1
SCHEMBL14588484 0.78 FNTA (0.49) FNTAFNTBPGGT1BTP53MAPT
SCHEMBL5561322 0.78 FNTA (0.56) FNTAFNTBRORBCSNK2A2CSNK2B
SCHEMBL14588483 0.77 FNTA (0.52) FNTAFNTBPGGT1BCHEK1LIMK1
SCHEMBL13501483 0.76 FNTA (0.51) FNTAFNTBPGGT1BCHEK1LIMK1
SCHEMBL6794461 0.76 FNTA (0.46) FNTAFNTBPGGT1BCHEK1LIMK1
SCHEMBL14588558 0.75 FNTA (0.60) FNTAFNTBPGGT1BRORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040048882-A1 Farnesyl transferase inhibiting 6-(substituted phenyl) Methy)-quinoline and quinazoline derinazoline derivaties JANSSEN-CILAG S.A. (FR) 2004-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040048882-A1 Farnesyl transferase inhibiting 6-(substituted phenyl) Methy)-quinoline and quinazoline derinazoline derivaties FNTB, FNTA, CYP7A1 FNTA 2/4885FNTB 1/4885PGGT1B 83/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.